This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Editors' Note: In this week's WriteClick, correspondence focuses on questions of cost, both in theory and in practice. Dr. Kelley suggests alternative explanations for why the more “expensive” (placebo) injection worked better than the “cheap” (placebo) injection only when administered first in “Placebo effect of medication cost in Parkinson disease: A randomized double-blind study.” Authors Espay et al. respond and address the controversy of “authorized deception.” Dr. Alpert questions the necessity of the diagnostic expense accrued in the case of “Biopsy-negative PET-positive giant-cell arteritis.” Authors Saidha and Al-Louzi recommend an individualized approach to diagnosis, taking into consideration both the patient and the price.—Megan Alcauskas, MD, and Robert C. Griggs, MD
I commend Espay et al.1 for their innovative article, in which table 1 showed that “expensive” injections produced more improvement than “cheap” injections, but only when “expensive” injections were first. When “cheap” injections were first, results were reversed. The authors …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
